Hit 14
Hit 14 is an inhibitor for C-X-C chemokine receptor type 4 (CXCR4) with IC50 of 254 nM. Hit 14 inhibits the migration and invasion of cell MDA-MB-231. Hit 14 inhibits the Akt phosphorylation, exhibits anti-inflammatory activity, and ameliorateds the ear swelling and damage in mouse models[1].
Product Specifications
CAS Number
440338-68-1
UNSPSC
12352005
Target
Akt; CXCR
Type
Reference compound
Related Pathways
GPCR/G Protein; Immunology/Inflammation; PI3K/Akt/mTOR
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/hit-14.html
Purity
99.0
Smiles
O=S(C1=CC=C(OC2=CC=C(S(=O)(NCC3OCCC3)=O)C=C2)C=C1)(NCC4OCCC4)=O
Molecular Formula
C22H28N2O7S2
Molecular Weight
496.60
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CXCR4
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![1,2-Dihydro-benz[j]aceanthrylen-2-ol-13C2,d4 and 5,6-Dihydro-benz[e]aceanthrylen-6-ol-13C2,d4](https://cdn.genprice.uk/products/572/1017467952520/imageurl/trc-d448412-1mg.webp)
TRC-D448412-1MG 1 mg
1,2-Dihydro-benz[j]aceanthrylen-2-ol-13C2,d4 and 5,6-Dihydro-benz[e]aceanthrylen-6-ol-13C2,d4
Sign In for Pricing
View Details